No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Barclays Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $29
Arcus Biosciences (RCUS) Receives a Buy From Barclays
BeiGene Slips on Decision to Halt Lung Cancer Program
Arcus Biosciences' US$134m Market Cap Fall Books Insider Losses
Arcus Biosciences, Inc.'s (NYSE:RCUS) Latest 8.6% Decline Adds to One-year Losses, Institutional Investors May Consider Drastic Measures
Arcus Biosciences Announces New Employment Inducement Grants